Literature DB >> 15890932

The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcription.

Eva Forgacs1, Saurabh K Gupta, Julie A Kerry, O John Semmes.   

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) viral protein Tax is a transactivator of transcription driven by the cognate viral long terminal repeat (LTR). Tax exerts its effect through three nonidentical copies of the Tax-responsive element (TxRE), a member of the asymmetric cyclic AMP response element (CRE) family of enhancer sequences. Transactivation is mediated via interaction of Tax with members of the CREB/ATF family bound to TxRE. We have identified a cellular repressor of transcription, activating transcription factor x (ATFx), as a novel Tax-binding protein. In addition to binding directly to Tax we show by electrophoretic mobility shift assay that ATFx binds to the TxRE enhancer element via the bZIP domain. The functional impact of this bridging interaction results in repression of both basal and Tax-induced transcription from the HTLV-1 LTR. ATFx is unique among ATF family of proteins in that it is cell cycle regulated and exerts a tight repressive control over apoptotic signaling. We propose that recruitment of ATFx to the HTLV-1 LTR serves to link viral transcription with critical events in cellular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890932      PMCID: PMC1112100          DOI: 10.1128/JVI.79.11.6932-6939.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer.

Authors:  L J Zhao; C Z Giam
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat.

Authors:  J Brady; K T Jeang; J Duvall; G Khoury
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

3.  PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner.

Authors:  H Jiang; H Lu; R L Schiltz; C A Pise-Masison; V V Ogryzko; Y Nakatani; J N Brady
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

4.  Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction.

Authors:  L J Zhao; C Z Giam
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

5.  Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins.

Authors:  O J Semmes; K T Jeang
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Molecular mechanisms of regulation of HTLV-1 gene expression and its association with leukemogenesis.

Authors:  M Yoshida; J Inoue; J Fujisawa; M Seiki
Journal:  Genome       Date:  1989       Impact factor: 2.166

7.  HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene.

Authors:  K T Jeang; S G Widen; O J Semmes; S H Wilson
Journal:  Science       Date:  1990-03-02       Impact factor: 47.728

8.  Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-1 Tax protein.

Authors:  C Alexandre; B Verrier
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

9.  The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1.

Authors:  T Suzuki; J I Fujisawa; M Toita; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I.

Authors:  J Fujisawa; M Seiki; M Sato; M Yoshida
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

View more
  7 in total

1.  Overexpression of activating transcription factor 5 in human rectal cancer.

Authors:  Xiangheng Kong; Wenjian Meng; Zongguang Zhou; Yuan Li; Bin Zhou; Rong Wang; Lan Zhan
Journal:  Exp Ther Med       Date:  2011-06-27       Impact factor: 2.447

2.  Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.

Authors:  Isabelle Lemasson; Matthew R Lewis; Nicholas Polakowski; Patrick Hivin; Marie-Hélène Cavanagh; Sabine Thébault; Benoit Barbeau; Jennifer K Nyborg; Jean-Michel Mesnard
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

3.  Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors.

Authors:  Dan Rauch; Shimon Gross; John Harding; Stefan Niewiesk; Michael Lairmore; David Piwnica-Worms; Lee Ratner
Journal:  Blood       Date:  2008-10-29       Impact factor: 22.113

4.  Schizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes.

Authors:  C J Carter
Journal:  J Pathog       Date:  2011-05-26

5.  An activating transcription factor 5-mediated survival pathway as a target for cancer therapy?

Authors:  Zhi Sheng; Sara K Evans; Michael R Green
Journal:  Oncotarget       Date:  2010-10

Review 6.  The HTLV-1 Tax interactome.

Authors:  Mathieu Boxus; Jean-Claude Twizere; Sébastien Legros; Jean-François Dewulf; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2008-08-14       Impact factor: 4.602

7.  Expression of activating transcription factor 5 (ATF5) is mediated by microRNA-520b-3p under diverse cellular stress in cancer cells.

Authors:  Kari A Gaither; Christy J W Watson; Bhanupriya Madarampalli; Philip Lazarus
Journal:  PLoS One       Date:  2020-06-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.